Medical device and life science development group Sunrise Labs said this week that it completed its succession plan, with president Eric Soederberg acquiring the majority of shares in the company through a stock sale with founder and board chair Drew Sunstein. With the transaction, the Bedford, N.H.-based company said that it secured its planned ownership […]
Cohera Medical said this week that the FDA granted investigational device exemption for a clinical trial of its Sylys surgical sealant. Raleigh, N.C.-based Cohera said the Sylys sealant, which won expedited access pathway status back in June 2015, is designed to be an adjunct to standard closure techniques in intestinal anastomosis procedures. The resorbable synthetic sealant aims […]
Before Patrick Daly was tapped as chairman of AdvaMed’s Accel unit, which represents emerging medical device companies, the CEO of Cohera Medical sat down with MassDevice.com Executive Editor Brad Perriello at DeviceTalks Raleigh. Daly, who founded the absorbable surgical adhesives and sealants company in 2006, has led 4 funding rounds totaling $75M in capital and […]
AdvaMed taps Cohera CEO Daly for Accel chairmanship AdvaMed said it tapped Patrick Daly, president & CEO of Cohera Medical, to be the new chairman of its AdvaMed Accel division for smaller medical device companies. Daly, who’s been on the board at Accel since 2012 and on the AdvaMed board since 2014, replaces CVRx president […]
Cohera Medical raised a $50 million funding round led by private equity giant KKR and joined by a group of existing investors. Pittsburgh-based Cohera, which makes absorbable surgical adhesives and sealants, said it plans to use the proceeds for the U.S. launch of its TissiGlu adhesive and for clinical trials of its Sylys sealant, which won […]
Cohera Medical said Wednesday it received an expedited access pathway designation for its Sylys surgical sealant. Sylys is a resorbable synthetic sealant designed to help prevent anastomotic leaks during gastrointestinal surgery, the Pittsburgh, Penn.-based company said. Anastomotic leaks occur between sections of surgically joined intestine, and the surgical sealant helps support anastomosis during initial healing to […]
The FDA today said it granted pre-market approval to Cohera Medical‘s TissuGlu surgical sealant, making good on the approvable letter it sent to Cohera in early January.
January 6, 2015 by Mark Hollmer
Cohera Medical today said it received an "approvable letter" from the FDA for its TissuGlu surgical sealant, noting that it expects to win pre-market approval "within a few weeks."